Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |